BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22154278)

  • 21. The role of the insulin-like growth factor signaling pathway in non-small cell lung cancer and other solid tumors.
    Scagliotti GV; Novello S
    Cancer Treat Rev; 2012 Jun; 38(4):292-302. PubMed ID: 21907495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review of targeted agents for non-small cell lung cancer.
    Vestergaard HH; Christensen MR; Lassen UN
    Acta Oncol; 2018 Feb; 57(2):176-186. PubMed ID: 29172833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of molecular analyses in the diagnosis and treatment of non-small-cell lung carcinomas.
    Rossi G; Graziano P; Leone A; Migaldi M; Califano R
    Semin Diagn Pathol; 2013 Nov; 30(4):298-312. PubMed ID: 24342286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging targeted therapies in non-small cell lung cancer.
    Khanal N; Ganti AK
    Expert Rev Anticancer Ther; 2016; 16(2):177-87. PubMed ID: 26618563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting HER2 in the treatment of non-small cell lung cancer.
    Mar N; Vredenburgh JJ; Wasser JS
    Lung Cancer; 2015 Mar; 87(3):220-5. PubMed ID: 25601485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular profiling of non-small cell lung cancer].
    Gibault L; Cazes A; Narjoz C; Blons H
    Rev Pneumol Clin; 2014; 70(1-2):47-62. PubMed ID: 24566035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Personalized therapy for non-small cell lung cancer: which drug for which patient?
    Villaruz LC; Socinski MA
    Semin Thorac Cardiovasc Surg; 2011; 23(4):281-90. PubMed ID: 22443647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted therapy in non-small-cell lung cancer--is it becoming a reality?
    Janku F; Stewart DJ; Kurzrock R
    Nat Rev Clin Oncol; 2010 Jul; 7(7):401-14. PubMed ID: 20551945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer.
    Rebuzzi SE; Zullo L; Rossi G; Grassi M; Murianni V; Tagliamento M; Prelaj A; Coco S; Longo L; Dal Bello MG; Alama A; Dellepiane C; Bennicelli E; Malapelle U; Genova C
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Targets in Non-Small Cell Lung Cancer.
    Park SJ; More S; Murtuza A; Woodward BD; Husain H
    Hematol Oncol Clin North Am; 2017 Feb; 31(1):113-129. PubMed ID: 27912827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status of targeted therapy in non-small cell lung cancer.
    Parums DV
    Drugs Today (Barc); 2014 Jul; 50(7):503-25. PubMed ID: 25101332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting the MET pathway for potential treatment of NSCLC.
    Li A; Gao HF; Wu YL
    Expert Opin Ther Targets; 2015 May; 19(5):663-74. PubMed ID: 25532429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel therapeutic targets in non-small cell lung cancer.
    Janku F; Garrido-Laguna I; Petruzelka LB; Stewart DJ; Kurzrock R
    J Thorac Oncol; 2011 Sep; 6(9):1601-12. PubMed ID: 21849857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted therapies in development for non-small cell lung cancer.
    Reungwetwattana T; Dy GK
    J Carcinog; 2013; 12():22. PubMed ID: 24574860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advances in treatment of lung cancer with targeted therapy.
    Cagle PT; Chirieac LR
    Arch Pathol Lab Med; 2012 May; 136(5):504-9. PubMed ID: 22540298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted therapy for lung cancer: present and future.
    Aggarwal C
    Ann Palliat Med; 2014 Jul; 3(3):229-35. PubMed ID: 25841697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Targeted Therapy and Immune Checkpoint Blockers in Advanced Non-Small Cell Lung Cancer: A Review.
    Abdel Karim N; Kelly K
    Oncologist; 2019 Sep; 24(9):1270-1284. PubMed ID: 30914465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Advances on driver oncogenes of non-small cell lung cancer].
    Zhao J; Xiong J
    Zhongguo Fei Ai Za Zhi; 2015 Jan; 18(1):42-7. PubMed ID: 25603872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung cancer genotype-based therapy and predictive biomarkers: present and future.
    Cagle PT; Allen TC
    Arch Pathol Lab Med; 2012 Dec; 136(12):1482-91. PubMed ID: 23194040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted therapy in nonsmall cell lung cancer.
    Puri T
    Indian J Cancer; 2017; 54(1):83-88. PubMed ID: 29199670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.